WEHI-231 Cell Lysate for Immunoprecipaitation: sc-24800

WEHI-231 (IP) Cell Lysate is derived from WEHI-231 cells, a murine B-cell lymphoma cell line originally established from a BALB/c mouse. This lysate is prepared to study immune receptor signaling pathways, focusing on the complex processes of B-cell receptor (BCR) signaling and immunoglobulin production. Researchers utilize WEHI-231 (IP) Cell Lysate for immunoprecipitation (IP) assays, enabling the isolation and analysis of specific protein-protein interactions and post-translational modifications. The lysate is instrumental in investigating the molecular mechanisms of B-cell activation, differentiation, and tolerance. Key signaling molecules such as SYK, BLNK, BTK, and PLCγ2 are analyzed through western blotting, mass spectrometry, and immunoprecipitation techniques to explain their roles in BCR-mediated signaling cascades. This research provides insights into the activation and regulation of downstream pathways including NF-κB, PI3K/AKT, and MAPK, which are critical for B-cell proliferation and survival. Additionally, WEHI-231 (IP) Cell Lysate is employed in screening chemical modulators that affect BCR signaling, advancing our understanding of how these pathways contribute to the pathogenesis of B-cell lymphomas. By comparing these lysates with those from normal B cells, scientists can identify specific molecular alterations and potential targets for further research, enhancing our knowledge of B-cell biology and lymphoma mechanisms.